Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGB1 | P09429 | 2/20 | 0.47 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.43 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.43 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.41 |
| ▸ | AKR1C1 | Q04828 | 4/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
| ▸ | GABRD | O14764 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14124080 | 0.88 | HSD17B10 (0.61) | HMGB1CXCL12ALDH1A1HPGDHSD17B10 | |
| SCHEMBL11774380 | 0.84 | GABRP (0.48) | HMGB1CXCL12ALDH1A1HPGDHSD17B10 | |
| SCHEMBL5029492 | 0.83 | CSNK2A1 (0.58) | HMGB1CXCL12ALDH1A1HPGDHSD17B10 | |
| SCHEMBL39260 | 0.82 | ALDH1A1 (0.48) | HMGB1CXCL12ALDH1A1HPGDHSD17B10 | |
| SCHEMBL9324615 | 0.81 | KAT8 (0.50) | MCL1 | |
| SCHEMBL334415 | 0.81 | KAT8 (0.50) | MCL1 | |
| SCHEMBL7781047 | 0.81 | KAT8 (0.50) | MCL1 | |
| SCHEMBL9500875 | 0.81 | KAT8 (0.50) | MCL1 | |
| SCHEMBL15375739 | 0.81 | HMGB1 (0.48) | HMGB1CXCL12ALDH1A1HPGDHSD17B10 | |
| SCHEMBL3965068 | 0.80 | HSD17B10 (0.41) | HMGB1CXCL12ALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9890351-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2018-02-13 | — | — | US | disclosed |
| EP-2741731-B1 | ENCAPSULATES | PROCTER & GAMBLE (US) | 2017-05-17 | — | — | EP | disclosed |
| US-8889614-B2 | Encapsulates | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| EP-2468239-B1 | Encapsulates | PROCTER & GAMBLE INTERNAT OPERATIONS SA (CH) | 2013-09-18 | — | — | EP | disclosed |
| US-20130039962-A1 | ENCAPSULATES | ENCAPSYS, LLC | 2013-02-14 | — | — | US | disclosed |
| EP-2468239-A1 | Encapsulates | Procter & Gamble International Operations SA (CH) | 2012-06-27 | — | — | EP | disclosed |
| US-20120152268-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2012-06-21 | — | — | US | disclosed |
| US-20110105378-A1 | ENCAPSULATES | SMETS JOHAN | 2011-05-05 | — | — | US | disclosed |
| US-20110098209-A1 | ENCAPSULATES | SMETS JOHAN | 2011-04-28 | — | — | US | disclosed |
| US-20100190674-A1 | ENCAPSULATES | PROCTER & GAMBLE COMPANY, THE | 2010-07-29 | — | — | US | disclosed |
| US-20100190673-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130039962-A1 | ENCAPSULATES | ABCB4, PPIB, FLNB | HMGB1 682/4885CXCL12 3039/4885ALDH1A1 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.